Company Spotlight

BioTechnique

Aphena Pharma Solutions

1976 Chocolate Drive
Cookeville, TN 38501
United States
View Profile

Biosynth Carbosynth

4 Rietlistrasse,
Staad, SG 9422
Switzerland
View Profile


Contract Service Directory


PPD





Company Headquarters

929 North Front Street
Wilmington, NC 28401-3331
United States

Contract Service Directory

    Related Content

    • Analytical Services | Bioanalytical Services | Breaking News | CRO News | Facilities | Industry News
      PPD to Expand GMP Lab in Ireland

      PPD to Expand GMP Lab in Ireland

      Adding cell and gene therapy capabilities to support growing customer need.
      Tim Wright, Editor, Contract Pharma 04.29.21

    • Clinical Trials | CRO News | Information Technology
      PPD, Science 37 Partner to Advance Decentralized Trials

      PPD, Science 37 Partner to Advance Decentralized Trials

      PPD will leverage Science 37's DCT SaaS-based technology platform to design, build, test, implement and execute digital trials.
      Kristin Brooks 04.28.21

    • Breaking News | CRO News
      Thermo Fisher Scientific to Acquire PPD

      Thermo Fisher Scientific to Acquire PPD

      Further expands service offering to pharma and biotech customers in high growth clinical research services industry.


    • Breaking News | CRO News | Industry News
      Thermo Fisher Acquires PPD for $17.4B

      Thermo Fisher Acquires PPD for $17.4B

      Further expands service offering to pharma and biotech customers.
      Tim Wright, Editor, Contract Pharma 04.15.21

    • Clinical Trials | CRO News | Information Technology
      PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data

      PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data

      Jointly develop systemic lupus erythematosus assessment review process to enhance data quality and research site personnel experiences and efficiencies.
      Kristin Brooks 03.24.21

    • Clinical Trials | Drug Development
      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.
      Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21


    • Breaking News | Clinical Trials | Promotions & Moves
      Parexel Appoints Chief Patient Officer

      Parexel Appoints Chief Patient Officer

      Demonstrates the company’s commitment to elevating the patient perspective.
      Contract Pharma Staff 01.06.21

    • Financial Reports
      Financial Report: PPD

      Financial Report: PPD

      Clinical Development Services revenue up 19% to $1.0 billion in the quarter.
      Contract Pharma Staff 10.29.20

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
      Moderna Completes Enrollment in Phase III COVID-19 Vax Study

      Moderna Completes Enrollment in Phase III COVID-19 Vax Study

      COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.
      Contract Pharma Staff 10.22.20


    • Analytical Services | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing
      PPD to Open Multipurpose Clinical Research Lab in Suzhou

      PPD to Open Multipurpose Clinical Research Lab in Suzhou

      Will offer bioanalytical, biomarker and vaccine services for global and China-based biopharma customers.
      10.14.20

    • Clinical Trials | CRO News | Drug Development | Information Technology
      PPD Creates Real-world Research Unit

      PPD Creates Real-world Research Unit

      Combines medical affairs research ops and Evidera
      05.08.17

    • Clinical Trials | Drug Development | Formulation Development | Industry News
      Ligand Licenses Captisol-Enabled Ganaxolone

      Ligand Licenses Captisol-Enabled Ganaxolone

      Marinus has exclusive worldwide rights to Captisol-enabled ganaxolone for use in humans
      04.05.17


    • Clinical Trials | CRO News | Drug Development

      PPD, Frenova in Nephrology Services Collaboration

      Will leverage Frenova’s therapeutic expertise, data access, study startup times
      02.22.17